{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:05:01Z","timestamp":1784901901896,"version":"3.55.0"},"reference-count":24,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Curebound Equity grant","award":["IP#30337997"],"award-info":[{"award-number":["IP#30337997"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,3]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) screening reduces cancer incidence and mortality, but participation rates are suboptimal in the USA and associated with inequities in CRC outcomes for lower income and many racial\/ethnic minoritised groups. A novel, US Food and Drug Administration-approved cell-free tumour DNA (cfDNA) blood test has the potential to improve screening rates, but the impact of offering this test on participation, including among populations at disproportionately increased risk for inequities in CRC outcomes, has not been studied. We designed a small effectiveness randomised controlled trial (RCT) comparing a strategy of offering expanded options for CRC screening including a cfDNA test to a strategy of standard usual care options for screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This study is a two-arm, parallel-group RCT, with 1:1 randomisation of 340 patients to an intervention group versus a usual care group for CRC screening. Participants will include patients who are aged 45\u201375, not up-to-date with CRC screening and attending a routine primary care visit at Family Health Centers of San Diego, a Federally Qualified Health Center (FQHC) system serving a racial and ethnically diverse, low-income patient population. The intervention group will be offered choice of colonoscopy, at home faecal immunochemical test (FIT) or a combination of in clinic cfDNA and at home FIT. The usual care group will be offered a choice of colonoscopy or at home FIT. Both groups will receive education on the importance of screening and reminders to complete testing. Primary outcome is CRC screening completion within 60 days of enrolment, summarised as the proportion of all patients randomised by group, compared via a \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test of proportions. Secondary outcomes will include: number of abnormal results for each test modality, test results, number of patients with abnormal tests referred for abnormal test follow-up, and number of patients who completed colonoscopy within 90 days of an abnormal non-invasive test result.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the University of California, San Diego Office of Institutional Review Board Administration (811489). A waiver of documented (signed) consent was approved by and will allow for a pragmatic design that mimics usual care, in which all patients will be offered all options for CRC screening. Main results will be disseminated to trial participants via reporting of test results and study publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06929481\">NCT06929481<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116700","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:20:37Z","timestamp":1784899237000},"page":"e116700","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-based cell-free DNA for addressing colorectal cancer screening disparities: a study protocol for a randomised trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06929481","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5058-1302","authenticated-orcid":false,"given":"Nicole P","family":"Mirabadi","sequence":"first","affiliation":[{"name":"University of California San Diego School of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job G","family":"Godino","sequence":"additional","affiliation":[{"name":"Family Health Centers of San Diego, San Diego, California, USA"},{"name":"Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Macias Martinez","sequence":"additional","affiliation":[{"name":"Family Health Centers of San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Samaniego","sequence":"additional","affiliation":[{"name":"Family Health Centers of San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Le","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA"},{"name":"Moores Cancer Center, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, California, USA"},{"name":"Department of Internal Medicine, Division of Gastroenterology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2026072406202494000_16.7.e116700.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772"},{"key":"2026072406202494000_16.7.e116700.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304714"},{"key":"2026072406202494000_16.7.e116700.3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"2026072406202494000_16.7.e116700.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08678-8","article-title":"Increasing uptake of colon cancer screening in a medically underserved population with the addition of blood-based testing","volume":"21","author":"Ioannou","year":"2021","journal-title":"BMC Cancer"},{"key":"2026072406202494000_16.7.e116700.5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2468-1253(23)00188-7","article-title":"Blood-based colorectal cancer screening: are we ready for the next frontier?","volume":"8","author":"Wang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026072406202494000_16.7.e116700.6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330980"},{"key":"2026072406202494000_16.7.e116700.7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cgh.2024.01.034","article-title":"Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening","volume":"22","author":"Lieberman","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026072406202494000_16.7.e116700.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.03.011"},{"key":"2026072406202494000_16.7.e116700.9","doi-asserted-by":"crossref","DOI":"10.1177\/21501319241242571","article-title":"Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center","volume":"15","author":"Shareef","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"2026072406202494000_16.7.e116700.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2693","article-title":"Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer","volume":"7","author":"Ciemins","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026072406202494000_16.7.e116700.11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51384","article-title":"Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020","volume":"6","author":"Mohl","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026072406202494000_16.7.e116700.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32440"},{"key":"2026072406202494000_16.7.e116700.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2026072406202494000_16.7.e116700.14","unstructured":"The Annie E. Casey Foundation . Adult population by race and ethnicity: kids count data center. Baltimore (MD): The Annie E. Casey Foundation; 2025. Available: https:\/\/datacenter.aecf.org\/data\/tables\/6539-adult-population-by-race-and-ethnicity#detailed\/1\/any\/false\/1096,2545,1095,2048,574,1729,37,871,870,573\/2800,66,67,8367,69,70,71,12\/13517,13518"},{"key":"2026072406202494000_16.7.e116700.15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2105\/AJPH.2019.305524","article-title":"Outreach and Inreach Strategies for Colorectal Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015\u20132018","volume":"110","author":"Casta\u00f1eda","year":"2020","journal-title":"Am J Public Health"},{"key":"2026072406202494000_16.7.e116700.16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1540415320923564","article-title":"Development of a Group-Based Community Health Worker Intervention to Increase Colorectal Cancer Screening Among Latinos","volume":"19","author":"De La Torre","year":"2021","journal-title":"Hisp Health Care Int"},{"key":"2026072406202494000_16.7.e116700.17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1524839920912240","article-title":"A Promotor-Led Pilot Study to Increase Colorectal Cancer Screening in Latinos: The Juntos Contra El C\u00e1ncer Program","volume":"22","author":"Arredondo","year":"2021","journal-title":"Health Promot Pract"},{"key":"2026072406202494000_16.7.e116700.18","doi-asserted-by":"crossref","first-page":"107353","DOI":"10.1016\/j.cct.2023.107353","article-title":"Hub-and-Spoke centralized intervention to optimize colorectal cancer screening and follow-up: A pragmatic, cluster-randomized controlled trial protocol","volume":"134","author":"Casta\u00f1eda","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2026072406202494000_16.7.e116700.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93334-1","article-title":"The effect of deadlines on cancer screening completion: a randomized controlled trial","volume":"11","author":"Lieberman","year":"2021","journal-title":"Sci Rep"},{"key":"2026072406202494000_16.7.e116700.20","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0039"},{"key":"2026072406202494000_16.7.e116700.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11389"},{"key":"2026072406202494000_16.7.e116700.22","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.286"},{"key":"2026072406202494000_16.7.e116700.23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/cncr.29770","article-title":"Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system","volume":"122","author":"Singal","year":"2016","journal-title":"Cancer"},{"key":"2026072406202494000_16.7.e116700.24","first-page":"1725","article-title":"Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial","volume":"173","author":"Gupta","year":"2013","journal-title":"JAMA Intern Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:20:40Z","timestamp":1784899240000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,24]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-116700"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116700","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}